Chinese Academy of

Latest clinical program signals indexed for Chinese Academy of.

1. IIT2025111 — Phase 2

   Jun 8, 2026
   Clinical update →

2. 2026（225） — Phase 2

   Jun 8, 2026
   Clinical update →

3. [2025]372-001 — Phase 3

   Jun 8, 2026
   Clinical update →

4. NHL-014 — Phase 3

   Jun 8, 2026
   Clinical update →

5. DLY201619 — Phase 3

   Jun 8, 2026
   Clinical update →

6. CNBG-BIBP-O-2022003 — Phase 3

   Jun 8, 2026
   Clinical update →

7. JSVCT099 — Phase 2

   Jun 8, 2026
   Clinical update →

8. HX-H2112345 — Phase 3

   Jun 8, 2026
   Clinical update →

1. NCT00149578

   Gemcitabine Oxaliplatin 5FU and Leucovorin

   Phase 2 · active · small_molecule

   Pancreatic Cancer

   CT.gov ↗
2. NCT00201305

   Gemcitabine+5FU+Leucovorin

   Phase 2 · completed · small_molecule

   Biliary Tract Disease

   CT.gov ↗
3. NCT00201383

   cisplatin

   Phase 3 · completed · small_molecule

   Oral Cavity

   CT.gov ↗
4. NCT00208000

   Marine active

   Phase 2 · active · small_molecule

   "Hyperuricemia,Anserine"

   CT.gov ↗
5. NCT00316641

   Lipid-lowing Tea

   Phase 3 · active · small_molecule

   Hyperlipidemia

   CT.gov ↗
6. NCT00328276

   Sarcosine

   Phase 2 · completed · small_molecule

   Schizophrenias

   CT.gov ↗
7. NCT00359333

   Gemcitabine , Docetaxel

   Phase 2 · completed · small_molecule

   Sarcoma

   CT.gov ↗
8. NCT00455286

   Methotrexate

   Phase 2 · active · small_molecule

   Primary Central Nervous System Lymphoma

   CT.gov ↗
9. NCT00461942

   Green Tea Polyphenols (EGCG/ECG)

   Phase 2 · completed · small_molecule

   Parkinson's Disease

   CT.gov ↗
10. NCT00463294

    Coronary Artery Bypass Graft with the use of CPB

    Phase 3 · completed · other

    the Efficacy and Safety of Off-pump CABG

    CT.gov ↗
11. NCT00508482

    Lactulose

    Phase 2 · completed · small_molecule

    Constipation

    CT.gov ↗
12. NCT00529295

    misoprostol

    Phase 3 · completed · small_molecule

    Labor Induction

    CT.gov ↗
13. NCT00698191

    Allogeneic MSC (AlloMSC)

    Phase 2 · active · mab

    Refractory Systemic Lupus Erythematosus

    CT.gov ↗
14. NCT00755664

    Low-dose complex B-vitamins

    Phase 3 · completed · other

    Hyperhomocysteinemia

    CT.gov ↗
15. NCT00776477

    clopidogrel and aspirin

    Phase 3 · active · small_molecule

    Atherosclerosis

    CT.gov ↗
16. NCT01013688

    Cardioblate® Surgical Ablation System

    Phase 3 · active · other

    Rheumatic Valve Disease

    CT.gov ↗
17. NCT01031927

    N-methyl glycine

    Phase 2 · completed · small_molecule

    Obsessive Compulsive Disorder

    CT.gov ↗
18. NCT01048190

    Inactivated Poliomyelitis Vaccine (Sabin strains)

    Phase 3 · completed · mab

    Poliomyelitis

    CT.gov ↗
19. NCT01053390

    Somatostatin

    Phase 3 · completed · small_molecule

    Gallbladder Neoplasms

    CT.gov ↗
20. NCT01054274

    novel stent

    Phase 3 · active · other

    Esophageal Cancer

    CT.gov ↗
21. NCT01068015

    behavior intervention and male circumcision

    Phase 3 · active · other

    HIV

    CT.gov ↗
22. NCT01087242

    Tang-min Lin pill

    Phase 3 · active · small_molecule

    Type 2 Diabetes

    CT.gov ↗
23. NCT01108614

    Intervention

    Phase 3 · active · other

    HIV

    CT.gov ↗
24. NCT01176565

    Intravenous nicardipine hydrochloride

    Phase 3 · terminated · small_molecule

    Intracerebral Hemorrhage

    CT.gov ↗
25. NCT01242254

    Intravitreal injection of KH902

    Phase 2 · completed · mab

    Neovascular Age-related Macular Degeneration

    CT.gov ↗
26. NCT01245959

    Docetaxel, cisplatin and fluorouracil

    Phase 3 · active · small_molecule

    Nasopharyngeal Carcinoma

    CT.gov ↗
27. NCT01251055

    GlyT-1 inhibitor-1

    Phase 2 · completed · small_molecule

    Schizophrenia

    CT.gov ↗
28. NCT01321749

    Remote ischemic preconditioning (RIPC)

    Phase 2 · completed · other

    Cerebrovascular Disease

    CT.gov ↗
29. NCT01325571

    Tacrolimus capsule

    Phase 3 · completed · small_molecule

    Myasthenia Gravis

    CT.gov ↗
30. NCT01328236

    Bortezomib

    Phase 2 · active · small_molecule

    Plasma Cell Leukemia

    CT.gov ↗
31. NCT01342016

    tacrolimus capsule

    Phase 3 · terminated · small_molecule

    Lupus Nephritis

    CT.gov ↗
32. NCT01350570

    Loperamide

    Phase 3 · completed · small_molecule

    Diarrhea-predominant Irritable Bowel Syndrome

    CT.gov ↗
33. NCT01351493

    Nitric Oxide

    Phase 2 · active · small_molecule

    Pressure Ulcer

    CT.gov ↗
34. NCT01368770

    Coronary CTA

    Phase 3 · completed · other

    Coronary Artery Disease

    CT.gov ↗
35. NCT01389583

    AUY922

    Phase 2 · active · small_molecule

    Gastrointestinal Stromal Tumor

    CT.gov ↗
36. NCT01398449

    Elective nodal irradiation (ENI)

    Phase 3 · active · other

    Esophageal Squamous Cell Carcinoma

    CT.gov ↗
37. NCT01405079

    Gefitinib

    Phase 3 · active · small_molecule

    Non-small Cell Lung Cancer

    CT.gov ↗
38. NCT01405248

    Butylphthalide

    Phase 3 · completed · small_molecule

    Restenosis

    CT.gov ↗
39. NCT01411501

    mosapride citrate

    Phase 3 · completed · small_molecule

    Constipation

    CT.gov ↗
40. NCT01428401

    Chinese Herb Astragalus membranaceus

    Phase 2 · completed · small_molecule

    Stroke

    CT.gov ↗
41. NCT01437514

    preoperative short-course radiotherapy

    Phase 3 · terminated · other

    Rectal Neoplasms

    CT.gov ↗
42. NCT01440829

    L-ornithine-L-aspartate

    Phase 3 · completed · small_molecule

    Decompensated Cirrhosis

    CT.gov ↗
43. NCT01476774

    Buprenorphine Transdermal System

    Phase 3 · completed · small_molecule

    Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)

    CT.gov ↗
44. NCT01506414

    rhTPO in combination with Rituximab

    Phase 3 · completed · small_molecule

    Purpura

    CT.gov ↗
45. NCT01510366

    Inactivated Poliomyelitis Vaccine (Sabin strains)

    Phase 3 · completed · mab

    Poliomyelitis

    CT.gov ↗
46. NCT01525836

    rituximab; recombinant human thrombopoietin (rhTPO)

    Phase 3 · completed · small_molecule

    Purpura

    CT.gov ↗
47. NCT01579630

    Pemetrexed 500mg/m2 iv

    Phase 3 · active · small_molecule

    NSCLC

    CT.gov ↗
48. NCT01580839

    Tissue Plasminogen Activator (Alteplase)

    Phase 3 · completed · small_molecule

    Stroke

    CT.gov ↗
49. NCT01603667

    PG2

    Phase 2 · completed · small_molecule

    Acute Stroke

    CT.gov ↗
50. NCT01642771

    5-Fu/epirubicin/CTX following Docetaxel

    Phase 3 · active · small_molecule

    Breast Cancer

    CT.gov ↗
51. NCT01682551

    Chinese Medicine

    Phase 2 · active · small_molecule

    Acute Mountain Sickness (AMS)

    CT.gov ↗
52. NCT01701778

    Caudal Dexmedetomidine

    Phase 2 · completed · small_molecule

    Inguinal Hernia

    CT.gov ↗
53. NCT01705223

    DNA vaccine

    Phase 2 · completed · mab

    AIDS

    CT.gov ↗
54. NCT01707615

    GSPE

    Phase 2 · completed · small_molecule

    Atherosclerosis of Arteries of the Extremities, Unspecified

    CT.gov ↗
55. NCT01712997

    Iloprost

    Phase 3 · active · small_molecule

    Pulmonary Arterial Hypertension

    CT.gov ↗
56. NCT01724697

    BMSC transplantation

    Phase 2 · active · other

    Liver Cirrhosis

    CT.gov ↗
57. NCT01728688

    PBSC transplantation

    Phase 2 · active · other

    Liver Cirrhosis

    CT.gov ↗
58. NCT01734044

    recombinant human thrombopoietin (rhTPO); dexamethasone

    Phase 3 · completed · small_molecule

    Purpura

    CT.gov ↗
59. NCT01734057

    recombinant human thrombopoietin (rhTPO); rituximab

    Phase 3 · terminated · small_molecule

    Purpura

    CT.gov ↗
60. NCT01763099

    Mesenchymal stem cells

    Phase 2 · active · mab

    Hematopoietic Stem Cell Transplantation

    CT.gov ↗
61. NCT01763385

    Erlotinib

    Phase 2 · active · small_molecule

    Non-small-cell Lung Cancer

    CT.gov ↗
62. NCT01794884

    Glutamine

    Phase 2 · completed · small_molecule

    Rheumatic Heart Disease

    CT.gov ↗
63. NCT01848873

    Amlodipine

    Phase 3 · active · small_molecule

    Essential Hypertension

    CT.gov ↗
64. NCT01855594

    Lithium Carbonate

    Phase 2 · completed · small_molecule

    Neuropathic Pain

    CT.gov ↗
65. NCT01872962

    gemcitabine and cisplatin (Induction chemotherapy)

    Phase 3 · active · small_molecule

    Nasopharyngeal Carcinoma

    CT.gov ↗
66. NCT01901705

    Indigo naturalis ointment

    Phase 2 · completed · small_molecule

    Psoriasis

    CT.gov ↗
67. NCT01925352

    Ad-HGF

    Phase 2 · active · small_molecule

    Ischemic Heart Disease

    CT.gov ↗
68. NCT01941342

    Pancreatoduodenectomy

    Phase 2 · active · other

    Pancreatic Cancer

    CT.gov ↗
69. NCT01965509

    PEX168 or placebo

    Phase 2 · completed · small_molecule

    Type 2 Diabetes

    CT.gov ↗
70. NCT01967875

    Capecitabine+Cisplatin

    Phase 2 · terminated · small_molecule

    Stomach Neoplasms

    CT.gov ↗
71. NCT01980849

    Nadroparin, long term

    Phase 3 · active · small_molecule

    Lung Cancer

    CT.gov ↗
72. NCT01985451

    Pemetrexe

    Phase 2 · active · small_molecule

    Central Nervous System Tumors

    CT.gov ↗
73. NCT02021097

    Levonorgestrel 100 mcg and Ethinyl Estradiol 20 mcg

    Phase 3 · active · small_molecule

    Oral Contraceptive

    CT.gov ↗
74. NCT02065388

    Genotype-guided dosingTaiwan algorithm for warfarin

    Phase 3 · completed · gene_therapy

    Stroke

    CT.gov ↗
75. NCT02066688

    folic acid

    Phase 3 · active · small_molecule

    Colorectal Neoplasms

    CT.gov ↗
76. NCT02072785

    Vincristine Sulfate Liposome

    Phase 3 · active · small_molecule

    Adult Acute Lymphoblastic Leukemia

    CT.gov ↗
77. NCT02083718

    PBSC

    Phase 2 · active · mab

    Stem Cell Transplantation, Hematopoietic

    CT.gov ↗
78. NCT02086942

    Bortezomib

    Phase 2 · active · small_molecule

    Multiple Myeloma

    CT.gov ↗
79. NCT02093195

    Bosentan

    Phase 2 · active · small_molecule

    Chronic Obstructive Pulmonary Disease (COPD)

    CT.gov ↗
80. NCT02094248

    TPO

    Phase 3 · active · small_molecule

    Sepsis

    CT.gov ↗
81. NCT02099396

    Docetaxel+lobaplatin

    Phase 3 · active · small_molecule

    Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma

    CT.gov ↗
82. NCT02110446

    SS-1

    Phase 2 · active · small_molecule

    Sjögren's Syndrome

    CT.gov ↗
83. NCT02110628

    Roux-en-Y anastomosis

    Phase 3 · active · other

    Gastric Cancer

    CT.gov ↗
84. NCT02139995

    RBC transfusion based on different protocols

    Phase 3 · active · other

    Transfusion Related Complication

    CT.gov ↗
85. NCT02150252

    Bu-Yang-Huan-Wu Tang

    Phase 2 · active · small_molecule

    Ischemic Stroke

    CT.gov ↗
86. NCT02179580

    Xiang-Sha-Liu-Jun-Zi-Tang

    Phase 3 · active · small_molecule

    Irritable Bowel Syndrome

    CT.gov ↗
87. NCT02203396

    IIT2014006

    Phase 2 · completed · small_molecule

    Aplastic Anemia

    CT.gov ↗
88. NCT02219672

    Triplitode

    Phase 3 · active · small_molecule

    AIDS/HIV PROBLEM

    CT.gov ↗
89. NCT02231281

    cART(TDF/AZT+3TC+LPV/r)

    Phase 3 · active · small_molecule

    Acute HIV Infection

    CT.gov ↗
90. NCT02241031

    MPs

    Phase 3 · active · mab

    Hematological Diseases

    CT.gov ↗
91. NCT02288195

    Oxaliplatin

    Phase 3 · active · small_molecule

    Rectal Neoplasms

    CT.gov ↗
92. NCT02291354

    Pectin

    Phase 2 · active · small_molecule

    Slow Transit Constipation

    CT.gov ↗
93. NCT02291770

    Mesenchymal Stromal Cells

    Phase 3 · active · mab

    Chronic Graft-Versus-Host Disease

    CT.gov ↗
94. NCT02313610

    Qinbudan

    Phase 2 · completed · small_molecule

    Pulmonary Tuberculosis

    CT.gov ↗
95. NCT02329730

    1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative

    Phase 2 · completed · mab

    Tuberculosis

    CT.gov ↗
96. NCT02336542

    5μg/ml ESAT6-CFP10 in left arm and TB-PPD in right arm

    Phase 2 · completed · mab

    Tuberculosis

    CT.gov ↗
97. NCT02339714

    Loratadine

    Phase 2 · completed · small_molecule

    Rhinitis, Allergic, Perennial

    CT.gov ↗
98. NCT02353988

    Bicalutamide

    Phase 2 · active · small_molecule

    Breast Neoplasms

    CT.gov ↗
99. NCT02355249

    MIE

    Phase 3 · active · other

    Esophageal Carcinoma

    CT.gov ↗
100. NCT02356991

     Famitinib

     Phase 2 · on hold · small_molecule

     Non-Small Cell Lung Cancer (NSCLC)

     CT.gov ↗
101. NCT02363400

     MEP

     Phase 3 · terminated · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
102. NCT02375152

     Anterior Capsulotomy

     Phase 3 · active · other

     Obsessive-Compulsive Disorder

     CT.gov ↗
103. NCT02389322

     5μg/ml ESAT6-CFP10

     Phase 2 · completed · mab

     Tuberculosis

     CT.gov ↗
104. NCT02398318

     Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)

     Phase 3 · terminated · other

     Obsessive Compulsive Disorder

     CT.gov ↗
105. NCT02440152

     Suzhou Sceneray® DBS System

     Phase 3 · active · other

     Opiate Addiction

     CT.gov ↗
106. NCT02444949

     Endostar

     Phase 2 · active · small_molecule

     Nasopharyngeal Neoplasms

     CT.gov ↗
107. NCT02452112

     5% Lidocaine patch

     Phase 3 · completed · small_molecule

     Herpes Zoster Pain

     CT.gov ↗
108. NCT02457221

     Tacrolimus capsules

     Phase 3 · completed · small_molecule

     Lupus Nephritis

     CT.gov ↗
109. NCT02463630

     Posterior Approach Compression Distraction Reduction

     Phase 3 · active · other

     Basilar Invagination Associated With Atlantoaxial Dislocation

     CT.gov ↗
110. NCT02482740

     Letrozole

     Phase 2 · active · small_molecule

     Uterine Cervical Neoplasms

     CT.gov ↗
111. NCT02525458

     QAMS-containing PMMA

     Phase 2 · completed · other

     Oral Health

     CT.gov ↗
112. NCT02526849

     Fecal microbiota transplantation (FMT)

     Phase 2 · active · small_molecule

     Slow Transit Constipation

     CT.gov ↗
113. NCT02544191

     GnRHa/ hCG/ hMG

     Phase 2 · active · small_molecule

     Azoospermia

     CT.gov ↗
114. NCT02550028

     Oral levetiracetam

     Phase 2 · terminated · small_molecule

     Neonatal Seizures

     CT.gov ↗
115. NCT02550054

     Epo

     Phase 2 · terminated · small_molecule

     Premature Infant

     CT.gov ↗
116. NCT02590679

     Venues-P Valve

     Phase 3 · active · other

     Pulmonary Regurgitation

     CT.gov ↗
117. NCT02616952

     Chinese herbal therapy

     Phase 2 · completed · other

     Urinary Incontinence, Stress

     CT.gov ↗
118. NCT02630108

     EADM

     Phase 3 · active · small_molecule

     Carcinoma, Hepatocellular

     CT.gov ↗
119. NCT02633202

     Cisplatin

     Phase 3 · completed · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
120. NCT02672280

     Medical Collagen Membrane with MSC

     Phase 2 · active · other

     Wounds

     CT.gov ↗
121. NCT02676388

     Freeze-dried, Capsulized FMT

     Phase 2 · active · other

     Slow Transit Constipation

     CT.gov ↗
122. NCT02705612

     Cisplatin

     Phase 2 · active · small_molecule

     Cervical Cancer

     CT.gov ↗
123. NCT02710149

     Anti-CD20-CAR-transduced T cells

     Phase 2 · active · mab

     Leukemia

     CT.gov ↗
124. NCT02713984

     Anti-HER2 CAR-T

     Phase 2 · terminated · mab

     Breast Cancer

     CT.gov ↗
125. NCT02720614

     Hypofractionated radiation/chemotherapy

     Phase 2 · completed · other

     Non-small Cell Lung Cancer

     CT.gov ↗
126. NCT02722642

     Bronchial basal cells

     Phase 2 · active · mab

     Bronchiectasis

     CT.gov ↗
127. NCT02725996

     NK cells

     Phase 2 · active · mab

     Hepatocellular Carcinoma

     CT.gov ↗
128. NCT02737085

     Anti-CD19 CAR-T cells and Anti-CD20 CAR-T cells

     Phase 2 · active · mab

     Lymphoma, Large B-Cell, Diffuse

     CT.gov ↗
129. NCT02739204

     Celecoxib

     Phase 2 · active · small_molecule

     Oral Squamous Cell Carcinoma

     CT.gov ↗
130. NCT02744274

     Verum acupuncture

     Phase 3 · active · other

     Colorectal Cancer

     CT.gov ↗
131. NCT02744742

     Decitabine

     Phase 3 · completed · small_molecule

     Myelodysplastic Syndrome

     CT.gov ↗
132. NCT02774187

     Sorafenib

     Phase 3 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
133. NCT02784093

     Gastrografin

     Phase 2 · active · small_molecule

     Fecal Impaction

     CT.gov ↗
134. NCT02785705

     poliovirus vaccine

     Phase 3 · completed · mab

     Poliomyelitis

     CT.gov ↗
135. NCT02846584

     CD19 or CD20 CAR T cells briging HSCT

     Phase 2 · active · mab

     Lymphoma, Large B-Cell, Diffuse

     CT.gov ↗
136. NCT02855645

     Trichosanthes root

     Phase 3 · active · small_molecule

     Diabetes Mellitus

     CT.gov ↗
137. NCT02868060

     Romiplostim

     Phase 2 · completed · small_molecule

     Immune Thrombocytopenia (ITP)

     CT.gov ↗
138. NCT02868099

     Romiplostim

     Phase 3 · completed · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
139. NCT02878863

     Paeoniflorin + phosphatidylcholine or silymarin

     Phase 3 · terminated · small_molecule

     Hepatitis, Autoimmune

     CT.gov ↗
140. NCT02889692

     YiQiFang

     Phase 3 · completed · small_molecule

     Cancer

     CT.gov ↗
141. NCT02900742

     YiQiFang

     Phase 3 · completed · small_molecule

     Cancer

     CT.gov ↗
142. NCT02902432

     Endostar

     Phase 2 · active · small_molecule

     Nasopharyngeal Neoplasms

     CT.gov ↗
143. NCT02940444

     Heparin

     Phase 2 · active · small_molecule

     Thromboprophylaxis

     CT.gov ↗
144. NCT02954445

     Anti-BCMA-CAR-transduced T cells

     Phase 2 · active · mab

     Leukemia

     CT.gov ↗
145. NCT02958111

     Capecitabine

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
146. NCT02958384

     Anti-LeY-CAR-transduced T cells

     Phase 2 · active · mab

     Myeloid Malignancies

     CT.gov ↗
147. NCT02958410

     Anti-CD30-CAR-transduced T cells

     Phase 2 · active · mab

     Leukemia

     CT.gov ↗
148. NCT02971345

     Epirubicin

     Phase 3 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
149. NCT02974426

     DLY201619

     Phase 3 · terminated · small_molecule

     Non-small Cell Lung Cancer Stage IIIA

     CT.gov ↗
150. NCT03002844

     EGFR-TK Inhibitor

     Phase 2 · active · small_molecule

     Nonsmall Cell Lung Cancer

     CT.gov ↗
151. NCT03004625

     daclatasvir

     Phase 3 · completed · small_molecule

     Hepatitis C

     CT.gov ↗
152. NCT03008798

     Herbal Medicine C-117

     Phase 2 · active · small_molecule

     Occlusion and Stenosis of Unspecified Cerebral Artery

     CT.gov ↗
153. NCT03013010

     Tegafur-Gimeracil-Oteracil Potassium

     Phase 3 · completed · small_molecule

     Stomach Neoplasm

     CT.gov ↗
154. NCT03016858

     Thoracoscopic Bullectomy Surgery

     Phase 3 · active · other

     Stability During Surgical Operation

     CT.gov ↗
155. NCT03021395

     Decitabine

     Phase 2 · terminated · small_molecule

     AML

     CT.gov ↗
156. NCT03027375

     Qishen Granules

     Phase 2 · active · small_molecule

     Heart Failure

     CT.gov ↗
157. NCT03031249

     Cytarabine

     Phase 3 · active · small_molecule

     AML

     CT.gov ↗
158. NCT03031262

     Cytarabine

     Phase 3 · active · small_molecule

     AML

     CT.gov ↗
159. NCT03116555

     Apatinib

     Phase 2 · active · small_molecule

     Metastatic Gastric Adenocarcinoma

     CT.gov ↗
160. NCT03130270

     Apatinib mesylate tablet

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
161. NCT03177382

     Adjuvant chemotherapy

     Phase 3 · active · small_molecule

     Total Neoadjuvant Treatment

     CT.gov ↗
162. NCT03179579

     HIPEC with neoadjuvant chemotherapy

     Phase 3 · active · other

     Gastric Cancer

     CT.gov ↗
163. NCT03180177

     neoadjuvant chemotherapy

     Phase 3 · active · small_molecule

     Epithelial Ovarian Cancer

     CT.gov ↗
164. NCT03186443

     Pregabalin

     Phase 3 · active · small_molecule

     Herpetic Neuralgia

     CT.gov ↗
165. NCT03188627

     Bronchial basal cells

     Phase 2 · completed · mab

     Chronic Obstructive Pulmonary Disease

     CT.gov ↗
166. NCT03201146

     Apatinib

     Phase 2 · active · small_molecule

     Lung Cancer

     CT.gov ↗
167. NCT03222674

     Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells

     Phase 2 · active · mab

     Acute Myeloid Leukemia

     CT.gov ↗
168. NCT03244605

     TCM

     Phase 3 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
169. NCT03271697

     Astragalus Membranaceus

     Phase 3 · active · small_molecule

     Aneurysmal Subarachnoid Hemorrhage

     CT.gov ↗
170. NCT03331588

     Subxiphoid uniportal VATS

     Phase 3 · completed · other

     Lung Neoplasms

     CT.gov ↗
171. NCT03349333

     pralatrexate

     Phase 3 · completed · small_molecule

     Refractory Peripheral T-Cell Lymphoma

     CT.gov ↗
172. NCT03351062

     Tamoxifen

     Phase 3 · active · small_molecule

     Breast Cancer Female

     CT.gov ↗
173. NCT03356444

     Abiraterone Acetate

     Phase 2 · active · small_molecule

     Prostate Cancer

     CT.gov ↗
174. NCT03387241

     Fluticasone/ Formoterol

     Phase 3 · active · small_molecule

     Asthma

     CT.gov ↗
175. NCT03394209

     Favipiravir

     Phase 2 · completed · small_molecule

     Influenza, Human

     CT.gov ↗
176. NCT03418155

     Treatment of TongBi Capsule

     Phase 3 · active · small_molecule

     Knee Osteoarthritis

     CT.gov ↗
177. NCT03468231

     Sorafenib

     Phase 3 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
178. NCT03489070

     Traumastem®

     Phase 3 · completed · other

     Liver Hemorrhage

     CT.gov ↗
179. NCT03500848

     Tacrolimus

     Phase 3 · active · small_molecule

     Liver Transplantation

     CT.gov ↗
180. NCT03521986

     Subxiphoid uniportal VATS

     Phase 3 · active · other

     Mediastinal Neoplasms

     CT.gov ↗
181. NCT03578575

     Danggui Buxue Tang

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
182. NCT03580239

     Everolimus

     Phase 3 · active · small_molecule

     Prostate Cancer

     CT.gov ↗
183. NCT03648697

     EBV-TCR-T (YT-E001) cells

     Phase 2 · active · mab

     Nasopharyngeal Carcinoma

     CT.gov ↗
184. NCT03656120

     0.2mg group

     Phase 2 · active · small_molecule

     Opioid Dependence

     CT.gov ↗
185. NCT03660059

     Peficitinib

     Phase 3 · completed · small_molecule

     Rheumatoid Arthritis (RA)

     CT.gov ↗
186. NCT03664518

     Eltrombopag

     Phase 2 · completed · small_molecule

     Thrombocytopenia Purpura

     CT.gov ↗
187. NCT03732001

     Anlotinib combined Docetaxel

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
188. NCT03749525

     shenfu injection

     Phase 3 · active · small_molecule

     Septic Shock

     CT.gov ↗
189. NCT03779646

     Bisoprolol Fumarate

     Phase 3 · active · small_molecule

     Duchenne Muscular Dystrophy

     CT.gov ↗
190. NCT03790800

     urapidil

     Phase 3 · completed · small_molecule

     Stroke, Acute

     CT.gov ↗
191. NCT03822507

     KHK7580

     Phase 3 · completed · small_molecule

     Secondary Hyperparathyroidism

     CT.gov ↗
192. NCT03823248

     MoLuoDan

     Phase 2 · active · small_molecule

     Gastric Precancerous Condition

     CT.gov ↗
193. NCT03837873

     Rituximab

     Phase 2 · active · small_molecule

     Diffuse Large B Cell Lymphoma

     CT.gov ↗
194. NCT03885388

     MTX

     Phase 3 · active · small_molecule

     Gestational Trophoblastic Tumor

     CT.gov ↗
195. NCT03909217

     Escitalopram

     Phase 3 · completed · small_molecule

     Mild-to-moderate Depression

     CT.gov ↗
196. NCT03914690

     Erythropoietin

     Phase 2 · completed · small_molecule

     Premature Infants

     CT.gov ↗
197. NCT03942094

     Nilotinib

     Phase 3 · active · small_molecule

     Chronic Myeloid Leukemia, Chronic Phase

     CT.gov ↗
198. NCT03990103

     S1

     Phase 2 · active · small_molecule

     Metastatic Gastric Adenocarcinoma

     CT.gov ↗
199. NCT04009915

     VATS

     Phase 3 · active · other

     Lung Cancer

     CT.gov ↗
200. NCT04035876

     Camrelizumab plus apatinib

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
201. NCT04061876

     Ruxolitinib

     Phase 2 · completed · small_molecule

     aGVHD

     CT.gov ↗
202. NCT04076059

     Enzalutamide

     Phase 3 · active · small_molecule

     Metastatic Hormone Sensitive Prostate Cancer

     CT.gov ↗
203. NCT04078737

     Ticagrelor and Aspirin

     Phase 3 · completed · small_molecule

     Stroke

     CT.gov ↗
204. NCT04098796

     Anti-PD-1 antibody

     Phase 2 · active · small_molecule

     Gastric or Gastroesophageal Junction Adenocarcinoma

     CT.gov ↗
205. NCT04110678

     NeuroEPO

     Phase 2 · completed · small_molecule

     Parkinson Disease

     CT.gov ↗
206. NCT04138992

     bevacizumab

     Phase 3 · active · small_molecule

     Disease Free Survival

     CT.gov ↗
207. NCT04146831

     Sintilimab

     Phase 2 · active · small_molecule

     Renal Cell Carcinoma

     CT.gov ↗
208. NCT04175587

     Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid

     Phase 3 · active · small_molecule

     Acute Promyelocytic Leukaemia

     CT.gov ↗
209. NCT04208646

     Mesenchymal progenitor cells

     Phase 2 · completed · mab

     Knee Osteoarthritis

     CT.gov ↗
210. NCT04213378

     Paclitaxel eluting PTCA balloon

     Phase 3 · active · other

     Coronary In-stent Restenosis

     CT.gov ↗
211. NCT04226950

     Recombinant Interferon Alpha

     Phase 2 · active · small_molecule

     Essential Thrombocytopenia

     CT.gov ↗
212. NCT04227808

     Lenvima 4 mg Oral Capsule

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
213. NCT04310865

     Yinhu Qingwen Granula

     Phase 3 · on hold · small_molecule

     COVID-19

     CT.gov ↗
214. NCT04320979

     internal mammary nodal irradiation

     Phase 3 · active · other

     Breast Cancer

     CT.gov ↗
215. NCT04322292

     C-CAR088

     Phase 2 · active · small_molecule

     Multiple Myeloma

     CT.gov ↗
216. NCT04323332

     Traditional Chinese Medicine Prescription

     Phase 3 · active · small_molecule

     COVID-19

     CT.gov ↗
217. NCT04387500

     Sintilimab injection plus Inlyta treatment

     Phase 2 · active · small_molecule

     Carcinoma, Renal Cell

     CT.gov ↗
218. NCT04397341

     CMUH-HO-NPC001

     Phase 2 · completed · small_molecule

     Locally Advanced Head and Neck Carcinoma

     CT.gov ↗
219. NCT04399785

     Camrelizumab and SBRT

     Phase 2 · active · other

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
220. NCT04414566

     2020HXFH037

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
221. NCT04470037

     DAAOI-P

     Phase 2 · completed · small_molecule

     Parkinson's Disease With Dementia

     CT.gov ↗
222. NCT04486430

     Neu2000KWL

     Phase 2 · completed · small_molecule

     Stroke

     CT.gov ↗
223. NCT04507841

     Niraparib

     Phase 2 · active · small_molecule

     Ovarian Cancer

     CT.gov ↗
224. NCT04513301

     Sintilimab

     Phase 2 · active · small_molecule

     Lung Neoplasms

     CT.gov ↗
225. NCT04516616

     2020-S112

     Phase 2 · active · small_molecule

     Uterine Cervical Neoplasm

     CT.gov ↗
226. NCT04519983

     Aumolertinib Oral Tablet

     Phase 2 · active · small_molecule

     Lung Cancer Stage IV

     CT.gov ↗
227. NCT04522102

     Start antiplatelet monotherapy

     Phase 3 · completed · small_molecule

     Intracerebral Hemorrhage

     CT.gov ↗
228. NCT04547452

     Anti-PD-1 antibody drug named Sintilimab

     Phase 2 · active · small_molecule

     Stage IV HCC

     CT.gov ↗
229. NCT04600960

     Eltrombopag

     Phase 2 · active · small_molecule

     Chemotherapy-induced Thrombocytopenia

     CT.gov ↗
230. NCT04612673

     Sintilimab

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
231. NCT04623567

     Jiangtang Tiaozhi recipe

     Phase 2 · active · small_molecule

     Type2 Diabetes

     CT.gov ↗
232. NCT04636008

     Sintilimab

     Phase 2 · active · small_molecule

     Anti-PD-1 Antibody

     CT.gov ↗
233. NCT04637620

     NMDAE

     Phase 2 · active · small_molecule

     Major Depressive Disorder

     CT.gov ↗
234. NCT04640402

     JSVCT099

     Phase 2 · completed · mab

     COVID-19

     CT.gov ↗
235. NCT04667598

     Modified Wenxin Decoction

     Phase 2 · active · small_molecule

     Heart Failure

     CT.gov ↗
236. NCT04690192

     CNCT19

     Phase 2 · completed · mab

     Large B-cell Lymphoma

     CT.gov ↗
237. NCT04692376

     Mesenchymal stem cells

     Phase 2 · active · mab

     Chronic Graft-versus-host Disease

     CT.gov ↗
238. NCT04696939

     Atezolizumab

     Phase 2 · active · small_molecule

     Small-cell Lung Cancer

     CT.gov ↗
239. NCT04698941

     Albumin Paclitaxel

     Phase 2 · active · small_molecule

     Small Cell Lung Cancer

     CT.gov ↗
240. NCT04713956

     Granulocyte Colony-Stimulating Factor(G-CSF)

     Phase 3 · active · small_molecule

     Myelodysplastic Syndrome

     CT.gov ↗
241. NCT04728724

     Sintilimab

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer Stage III

     CT.gov ↗
242. NCT04740840

     Levamlodipine

     Phase 3 · completed · small_molecule

     Hypertension

     CT.gov ↗
243. NCT04747080

     Dexamethasone

     Phase 2 · active · small_molecule

     ITP

     CT.gov ↗
244. NCT04772287

     Toripalimab

     Phase 3 · active · small_molecule

     Non Small Cell Lung Cancer

     CT.gov ↗
245. NCT04778956

     Toripalimab

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
246. NCT04785261

     Methylhydroxypropylcellulose

     Phase 2 · active · small_molecule

     Dry Eye Disease

     CT.gov ↗
247. NCT04803955

     16mg，KB

     Phase 2 · active · small_molecule

     Sepsis

     CT.gov ↗
248. NCT04839471

     BI-754091 plus afatinib

     Phase 2 · completed · small_molecule

     Esophageal Squamous Cell Carcinoma (ESCC)

     CT.gov ↗
249. NCT04856137

     Rituximab Paclitaxel Ruxolitinib

     Phase 2 · active · small_molecule

     Refractory Diffuse Large B-cell Lymphoma

     CT.gov ↗
250. NCT04885270

     cisplatin i.p.

     Phase 3 · active · small_molecule

     Epithelial Carcinoma, Ovarian

     CT.gov ↗
251. NCT04892212

     Sirolimus

     Phase 3 · active · small_molecule

     Lupus Nephritis

     CT.gov ↗
252. NCT04912167

     Sacubitril-Valsartan

     Phase 3 · active · small_molecule

     STEMI

     CT.gov ↗
253. NCT04915482

     Combined use of TPO-RAs with low-dose anti-CD20 antibody

     Phase 3 · active · small_molecule

     Immune Thrombocytopenia (ITP)

     CT.gov ↗
254. NCT04917523

     SARS-CoV-2 Vaccine (Vero Cell), Inactivated

     Phase 3 · completed · mab

     COVID-19 Pneumonia

     CT.gov ↗
255. NCT04917770

     Sintilimab in combination with Multimodality Radiotherapy

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
256. NCT04922853

     Capox chemotherapy

     Phase 3 · active · small_molecule

     Rectal Cancer

     CT.gov ↗
257. NCT04934514

     IAH0968

     Phase 2 · active · mab

     Advanced Solid Tumor

     CT.gov ↗
258. NCT04947345

     Remimazolam Besylate

     Phase 3 · active · small_molecule

     Analgesia

     CT.gov ↗
259. NCT04950647

     Nitrofurazone Group 1

     Phase 2 · active · small_molecule

     Amyotrophic Lateral Sclerosis

     CT.gov ↗
260. NCT04985201

     Irinotecan

     Phase 2 · active · small_molecule

     Small Cell Lung Cancer

     CT.gov ↗
261. NCT04988971

     a compound glutamine capsule

     Phase 3 · active · small_molecule

     Mucositis

     CT.gov ↗
262. NCT04992377

     R-EPOCH in Combination With Ibrutinib

     Phase 2 · active · small_molecule

     Richter Transformation

     CT.gov ↗
263. NCT04993885

     Avatrombopag

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
264. NCT04999332

     LOTS-GC-01

     Phase 2 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
265. NCT05026905

     Gemcitabine 1000 mg

     Phase 2 · active · small_molecule

     Phase II, Open-label, Parallel 2-arm, Multi-center

     CT.gov ↗
266. NCT05033847

     Recombinant COVID-19 Vaccine (CHO cell)

     Phase 2 · active · mab

     COVID-19 Pneumonia

     CT.gov ↗
267. NCT05052853

     NMDAE

     Phase 2 · active · small_molecule

     Prodromal Schizophrenia

     CT.gov ↗
268. NCT05069129

     Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)

     Phase 2 · active · mab

     COVID-19 Pneumonia

     CT.gov ↗
269. NCT05091619

     2016L10765-2

     Phase 3 · active · mab

     Whooping Cough

     CT.gov ↗
270. NCT05092113

     a compound glutamine capsule/a compound glutamine capsule simulated placebo

     Phase 3 · active · small_molecule

     Mucositis

     CT.gov ↗
271. NCT05097209

     Camrelizumab

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
272. NCT05105412

     Lenalidomide and Gemcitabine (Dose level 11)

     Phase 2 · terminated · small_molecule

     Peripheral T-cell Lymphomas (PTCL)

     CT.gov ↗
273. NCT05113888

     Qizhi weitong granules(High）

     Phase 2 · active · small_molecule

     Irritable Bowel Syndrome

     CT.gov ↗
274. NCT05136755

     NMDAE

     Phase 2 · active · small_molecule

     Major Depressive Disorder

     CT.gov ↗
275. NCT05147844

     Toripalimab

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
276. NCT05173441

     Human COVID-19 immunoglobulin (pH4) for intravenous injection

     Phase 2 · active · mab

     COVID-19

     CT.gov ↗
277. NCT05179733

     NHL-014

     Phase 3 · active · small_molecule

     Diffuse Large B-Cell Lymphoma

     CT.gov ↗
278. NCT05236582

     Herombopag

     Phase 2 · active · small_molecule

     Chemotherapy-induced Thrombocytopenia

     CT.gov ↗
279. NCT05240976

     NMDAE plus AIFA

     Phase 2 · active · small_molecule

     Schizophrenia

     CT.gov ↗
280. NCT05281068

     Iguratimod

     Phase 2 · active · small_molecule

     ITP

     CT.gov ↗
281. NCT05287984

     BDH-CLL-002-2022/02/14

     Phase 2 · active · small_molecule

     Chronic Lymphocytic Leukemia

     CT.gov ↗
282. NCT05293548

     Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)

     Phase 2 · active · mab

     COVID-19

     CT.gov ↗
283. NCT05294055

     Etoposide

     Phase 2 · active · small_molecule

     Multiple Myeloma

     CT.gov ↗
284. NCT05356351

     RC48- ADC

     Phase 2 · active · small_molecule

     Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance

     CT.gov ↗
285. NCT05365724

     CNBG-BIBP-O-2022003

     Phase 3 · active · mab

     COVID-19

     CT.gov ↗
286. NCT05374954

     CNBG-BIBP-O-2022003

     Phase 3 · active · mab

     COVID-19

     CT.gov ↗
287. NCT05395507

     Recombinant Interferon Alpha

     Phase 2 · active · small_molecule

     Essential Thrombocytopenia

     CT.gov ↗
288. NCT05406882

     HX-H2112345

     Phase 3 · active · small_molecule

     Radiation Proctitis

     CT.gov ↗
289. NCT05426811

     Regorafenib

     Phase 2 · active · small_molecule

     Regorafenib

     CT.gov ↗
290. NCT05433922

     Avatrombopag

     Phase 2 · active · small_molecule

     Severe Aplastic Anemia

     CT.gov ↗
291. NCT05453552

     Granulocyte Colony-Stimulating Factor(G-CSF)

     Phase 3 · active · small_molecule

     Myelodysplastic Syndrome

     CT.gov ↗
292. NCT05456698

     Inotuzumab ozogamicin

     Phase 2 · active · small_molecule

     Acute Lymphocytic Leukemia

     CT.gov ↗
293. NCT05465889

     Oral sulfate solution (OSS)

     Phase 3 · completed · small_molecule

     Bowel Preparation for Colonoscopy

     CT.gov ↗
294. NCT05470777

     CD22/CD19 CAR T and auto-HSCT "sandwich" strategy

     Phase 2 · active · other

     B-cell Acute Lymphoblastic Leukemia

     CT.gov ↗
295. NCT05476874

     Open Mini-Laparotomy

     Phase 2 · active · other

     Hydrocephalus

     CT.gov ↗
296. NCT05491811

     Ensartinib

     Phase 2 · active · small_molecule

     Non-Small Cell Lung Cancer

     CT.gov ↗
297. NCT05492669

     Lidocaine Hydrochloride, Injectable

     Phase 2 · active · small_molecule

     Postoperative Chronic Pain

     CT.gov ↗
298. NCT05496166

     chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

     Phase 3 · active · other

     Limited Stage Small Cell Lung Cancer

     CT.gov ↗
299. NCT05503667

     Furmonertinib

     Phase 2 · active · small_molecule

     Lung Adenocarcinoma Stage III

     CT.gov ↗
300. NCT05516589

     Nab-paclitaxel

     Phase 2 · completed · small_molecule

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
301. NCT05527470

     Gemcitabine,Cisplatin

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
302. NCT05544253

     mitomycin C-based hyperthermic intraperitoneal chemotherapy

     Phase 3 · active · other

     Hepatocellular Carcinoma

     CT.gov ↗
303. NCT05562882

     Daratumumab Injection

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
304. NCT05579132

     MK-1045

     Phase 2 · active · small_molecule

     Acute Lymphoblastic Leukemia

     CT.gov ↗
305. NCT05582265

     Tislelizumab（neoadjuvant）

     Phase 3 · active · small_molecule

     Head and Neck Squamous Cell Carcinomas

     CT.gov ↗
306. NCT05594095

     PIK3CA inhibitor

     Phase 2 · active · small_molecule

     Breast Neoplasm

     CT.gov ↗
307. NCT05594784

     Olverembatinib

     Phase 2 · completed · small_molecule

     Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

     CT.gov ↗
308. NCT05618470

     Wumeiwan Jiawei Fang

     Phase 3 · active · small_molecule

     Dry Eye Syndromes

     CT.gov ↗
309. NCT05632380

     C-CAR088

     Phase 2 · active · small_molecule

     Multiple Myeloma

     CT.gov ↗
310. NCT05638776

     REGEND001 cell therapy

     Phase 2 · completed · small_molecule

     Chronic Obstructive Pulmonary Disease

     CT.gov ↗
311. NCT05641909

     Remifentanil

     Phase 3 · active · small_molecule

     Analgesia

     CT.gov ↗
312. NCT05660785

     Herombopag

     Phase 2 · completed · small_molecule

     Non Severe Aplastic Anemia

     CT.gov ↗
313. NCT05662813

     Almonertinib

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
314. NCT05675813

     CHOP+selinexor+5-Azacitidine

     Phase 2 · active · small_molecule

     Peripheral T Cell Lymphoma

     CT.gov ↗
315. NCT05694767

     CM313 Injection

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
316. NCT05720234

     Avatrombopag

     Phase 2 · active · small_molecule

     Severe Aplastic Anemia

     CT.gov ↗
317. NCT05739188

     Anti-GPRC5D CAR-T cells infusion

     Phase 2 · active · mab

     Multiple Myeloma in Relapse

     CT.gov ↗
318. NCT05748938

     RD14-01

     Phase 2 · active · mab

     Solid Tumor

     CT.gov ↗
319. NCT05757479

     Steroid nasal spray

     Phase 3 · active · small_molecule

     Radiation-Induced Mucositis

     CT.gov ↗
320. NCT05759546

     Fluzoparib

     Phase 3 · active · small_molecule

     Breast Cancer Metastatic

     CT.gov ↗
321. NCT05759572

     Apatinib

     Phase 2 · active · small_molecule

     Breast Cancer Metastatic

     CT.gov ↗
322. NCT05763927

     Fruquintinib

     Phase 2 · active · small_molecule

     Rectal Cancer

     CT.gov ↗
323. NCT05776940

     Probiotic in AL amyloidosis

     Phase 3 · active · small_molecule

     Immunoglobulin Light-chain Amyloidosis

     CT.gov ↗
324. NCT05782894

     Remimazolam besylate

     Phase 3 · completed · small_molecule

     Sedative

     CT.gov ↗
325. NCT05792995

     Sindillimab

     Phase 2 · completed · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
326. NCT05797883

     FOLFOX/FOLFIRI

     Phase 2 · active · small_molecule

     Unresectable or Metastatic Colorectal Cancer

     CT.gov ↗
327. NCT05800223

     Almonertinib

     Phase 3 · active · small_molecule

     Non-small Cell Lung Cancer Metastatic

     CT.gov ↗
328. NCT05846750

     Obinutuzumab

     Phase 2 · active · small_molecule

     Marginal Zone Lymphoma

     CT.gov ↗
329. NCT05847348

     68Ga-PSMA-11

     Phase 3 · active · small_molecule

     Biochemical Recurrence of Malignant Neoplasm of Prostate

     CT.gov ↗
330. NCT05852847

     Baricitinib 2 MG [Olumiant]

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
331. NCT05877872

     Adjuvant immunotherapy

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
332. NCT05894889

     Pembrolizumab 200 mg IV infusion

     Phase 2 · active · mab

     Stage IIIB(N2) Non-small Cell Lung Cancer

     CT.gov ↗
333. NCT05905848

     2023(728)

     Phase 3 · active · small_molecule

     Carotid Stenosis

     CT.gov ↗
334. NCT05914714

     Ruxolitinib 5 MG BID Oral Tablet

     Phase 2 · active · small_molecule

     The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA

     CT.gov ↗
335. NCT05916326

     Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)

     Phase 3 · completed · mab

     Norovirus Infections

     CT.gov ↗
336. NCT05969587

     5% cysteamine cream

     Phase 3 · completed · other

     Melasma

     CT.gov ↗
337. NCT05981157

     Anrotinib plus Tirelizumab

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
338. NCT05983952

     Anti-CD38 antibody Injection

     Phase 2 · active · small_molecule

     Antiphospholipid Syndrome

     CT.gov ↗
339. NCT05991518

     Injection of IAH0968+Gemcitabine+Cisplatin

     Phase 2 · active · other

     HER2 Gene Mutation

     CT.gov ↗
340. NCT05991583

     IBB0979

     Phase 2 · active · small_molecule

     Advanced Malignant Tumors

     CT.gov ↗
341. NCT05995054

     Obinutuzumab Injection [Gazyva]

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
342. NCT06021197

     NMDAE

     Phase 2 · active · small_molecule

     Schizophrenia

     CT.gov ↗
343. NCT06026878

     AFMMUChina

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
344. NCT06031012

     glutamine combined with thalidomide

     Phase 3 · completed · small_molecule

     Mucositis Oral

     CT.gov ↗
345. NCT06041061

     Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）

     Phase 3 · active · mab

     HPV InfectioN

     CT.gov ↗
346. NCT06068621

     S2023-056-01

     Phase 2 · completed · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
347. NCT06078969

     Prednisone

     Phase 2 · active · small_molecule

     Langerhans Cell Histiocytosis of Bone

     CT.gov ↗
348. NCT06084819

     S2023-413-01

     Phase 2 · active · small_molecule

     Relapsed/Refractory Acute Myeloid Leukemia

     CT.gov ↗
349. NCT06085365

     Immunonutrition （Su yusu)

     Phase 3 · active · small_molecule

     Gastrointestinal Tumors

     CT.gov ↗
350. NCT06094881

     Obinutuzumab Injection [Gazyva]

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
351. NCT06134271

     Rezvilutamide

     Phase 2 · active · small_molecule

     Metastatic Hormone-Sensitive Prostate Cancer

     CT.gov ↗
352. NCT06134622

     Intravenous thrombolysis plus tirofiban

     Phase 3 · completed · small_molecule

     Acute Ischemic Stroke

     CT.gov ↗
353. NCT06177522

     Adebrelimab

     Phase 2 · active · small_molecule

     Pancreatic Cancer

     CT.gov ↗
354. NCT06199089

     CM313 Injection

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
355. NCT06202625

     avatrombopag

     Phase 3 · active · small_molecule

     Thrombocytopenia

     CT.gov ↗
356. NCT06223841

     IAP0971

     Phase 2 · active · small_molecule

     Advanced Malignant Tumors

     CT.gov ↗
357. NCT06224036

     JDB0131

     Phase 2 · active · small_molecule

     Drug-resistant Tuberculosis

     CT.gov ↗
358. NCT06241612

     Individualized Elective Neck Irradiation

     Phase 3 · active · other

     Nasopharyngeal Carcinoma

     CT.gov ↗
359. NCT06242418

     FOLFOXIRI

     Phase 2 · active · small_molecule

     Colon Cancer

     CT.gov ↗
360. NCT06244368

     GVM±R regimen

     Phase 2 · active · small_molecule

     Peripheral T Cell Lymphoma

     CT.gov ↗
361. NCT06254560

     Rituximab

     Phase 2 · active · small_molecule

     Severe Aplastic Anemia

     CT.gov ↗
362. NCT06255964

     IAP0971

     Phase 2 · active · small_molecule

     Bladder Cancer

     CT.gov ↗
363. NCT06256237

     JS004

     Phase 2 · active · small_molecule

     Limited Stage Small Cell Lung Cancer

     CT.gov ↗
364. NCT06287567

     Lusutrombopag Oral Tablet

     Phase 2 · completed · small_molecule

     Idiopathic Thrombocytopenic Purpura

     CT.gov ↗
365. NCT06289062

     Camrelizumab

     Phase 2 · active · small_molecule

     Cervical Cancer

     CT.gov ↗
366. NCT06289751

     Cadonilimab

     Phase 2 · active · small_molecule

     Cervical Cancer

     CT.gov ↗
367. NCT06292208

     IBD0333

     Phase 2 · active · mab

     MTD

     CT.gov ↗
368. NCT06312982

     Tislelizumab

     Phase 3 · active · small_molecule

     Locally Advanced Rectal Carcinoma

     CT.gov ↗
369. NCT06341296

     Irinotecan Liposome

     Phase 2 · active · small_molecule

     Metastatic Colorectal Cancer

     CT.gov ↗
370. NCT06349967

     Nab-paclitaxel Combined With Cadonilimab (AK104)

     Phase 2 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
371. NCT06397235

     DEB-TACE+HAIC

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma Non-resectable

     CT.gov ↗
372. NCT06405100

     Supportive care+Prednisone

     Phase 3 · active · small_molecule

     Minimal Change Disease

     CT.gov ↗
373. NCT06427005

     Fruquintinib

     Phase 2 · active · small_molecule

     Fruquintinib

     CT.gov ↗
374. NCT06437158

     Bleomycin

     Phase 2 · active · small_molecule

     Lymphatic Malformation

     CT.gov ↗
375. NCT06444009

     Ivonescimab combined with TP

     Phase 2 · active · small_molecule

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
376. NCT06453135

     Eculizumab

     Phase 2 · active · small_molecule

     Kidney Transplantation

     CT.gov ↗
377. NCT06463171

     Almonertinib

     Phase 2 · active · small_molecule

     Lung Cancer Non-small Cell Stage IV

     CT.gov ↗
378. NCT06464185

     Bispecific antibody-based combined with CAR-T cell therapy

     Phase 2 · active · small_molecule

     B-cell Non-Hodgkin Lymphoma

     CT.gov ↗
379. NCT06468358

     LB1410

     Phase 2 · active · small_molecule

     Solid Tumor

     CT.gov ↗
380. NCT06473909

     CD25 antibody combined glucocorticoid as first-line treatment

     Phase 2 · active · small_molecule

     Acute Graft Versus Host Disease

     CT.gov ↗
381. NCT06479759

     LM-108 antibody and sintilimab

     Phase 2 · active · small_molecule

     NSCLC

     CT.gov ↗
382. NCT06480136

     SHR-A1921 injection and adebrelimab injection

     Phase 2 · active · small_molecule

     NSCLC

     CT.gov ↗
383. NCT06508606

     AK117

     Phase 2 · active · small_molecule

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
384. NCT06509971

     QL1706

     Phase 2 · active · small_molecule

     Platinum-resistant Recurrent Ovarian Cancer

     CT.gov ↗
385. NCT06509997

     MRG003 combined with Dalpicicilip

     Phase 2 · active · small_molecule

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
386. NCT06518850

     Rifaximin

     Phase 2 · active · small_molecule

     Small Intestine Bacterial Overgrowth

     CT.gov ↗
387. NCT06525519

     ATLG

     Phase 3 · active · small_molecule

     Hematopoietic Stem Cell Transplantation

     CT.gov ↗
388. NCT06528847

     Benmelstobart

     Phase 2 · active · small_molecule

     Non-Small Cell Lung Cancer

     CT.gov ↗
389. NCT06530550

     PI3K inhibitor

     Phase 2 · active · small_molecule

     Lymphoma, T-Cell

     CT.gov ↗
390. NCT06530914

     MRG003 combined with Pucotenlimab

     Phase 2 · active · small_molecule

     Head and Neck Squamous Cell Carcinoma (HNSCC)

     CT.gov ↗
391. NCT06531525

     Enoxaparin

     Phase 2 · active · small_molecule

     Pregnancy Related

     CT.gov ↗
392. NCT06563245

     Brentuximab Vedotin for Injection

     Phase 3 · active · small_molecule

     Classical Hodgkin Lymphoma

     CT.gov ↗
393. NCT06574360

     S1RA plus NMDAE

     Phase 2 · active · small_molecule

     Schizophrenia

     CT.gov ↗
394. NCT06574581

     ADSC01

     Phase 2 · active · mab

     Connective Tissue Diseases

     CT.gov ↗
395. NCT06585644

     Furmonertinib in combination with Anrotinib and chemotherapy

     Phase 2 · active · small_molecule

     Lung Cancer (NSCLC)

     CT.gov ↗
396. NCT06592456

     Chickenpox Vaccines

     Phase 3 · completed · mab

     Chickenpox Vaccines

     CT.gov ↗
397. NCT06594172

     Memantine Oral Tablet

     Phase 2 · active · small_molecule

     Radiation Disease

     CT.gov ↗
398. NCT06594640

     Mitoxantrone Hydrochloride Liposome

     Phase 2 · active · small_molecule

     Diffuse Large B-cell Lymphoma

     CT.gov ↗
399. NCT06611839

     IIT2024067

     Phase 2 · active · small_molecule

     AML

     CT.gov ↗
400. NCT06612814

     Fluzoparib

     Phase 3 · active · small_molecule

     Breast Cancer Metastatic

     CT.gov ↗
401. NCT06614816

     Oka strain varicella attenuated live vaccine

     Phase 3 · completed · mab

     Chickenpox Vaccines

     CT.gov ↗
402. NCT06616259

     mCapOX plus Cetuximab

     Phase 3 · active · small_molecule

     Colorectal Cancer (CRC)

     CT.gov ↗
403. NCT06620822

     IBI363

     Phase 2 · active · small_molecule

     Non Small Cell Lung Cancer

     CT.gov ↗
404. NCT06639672

     Chemotherapy+PD-1 inhibitor+8Gy x 3f

     Phase 2 · active · small_molecule

     HR+HER2- Breast Cancer

     CT.gov ↗
405. NCT06658834

     Dexamethasone Combined with romiplostim N01

     Phase 2 · active · small_molecule

     Primary Immune Thrombocytopenia

     CT.gov ↗
406. NCT06663956

     a patient self-reporting applet

     Phase 3 · active · other

     Cancer Pain

     CT.gov ↗
407. NCT06664996

     Sintilimab (approved)

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
408. NCT06675422

     JY231 injection

     Phase 2 · active · small_molecule

     Systemic Lupus Erythematosus (SLE)

     CT.gov ↗
409. NCT06690346

     Systematic oral health education

     Phase 3 · completed · other

     Malignant Tumor of Head and/or Neck

     CT.gov ↗
410. NCT06696820

     PCSK9 inhibitors combined with atorvastatin/rosuvastatin

     Phase 3 · active · small_molecule

     Acute Ischemic Stroke

     CT.gov ↗
411. NCT06708156

     Atropine sulfate eye drops 0.01%

     Phase 3 · active · small_molecule

     Myopia

     CT.gov ↗
412. NCT06709885

     Chidamide + Tislelizumab + chemotherapy (CapeOX )

     Phase 2 · active · small_molecule

     Colon Adenocarcinoma

     CT.gov ↗
413. NCT06713057

     Cyclophosphamide+Pemetrexed+5-Fluorouracil

     Phase 2 · active · small_molecule

     Locally Advanced Thyroid Gland Carcinoma

     CT.gov ↗
414. NCT06719479

     IAE0972+ Methotrexate

     Phase 3 · active · mab

     NPC

     CT.gov ↗
415. NCT06744504

     Cytarabine

     Phase 3 · active · small_molecule

     AML

     CT.gov ↗
416. NCT06749886

     Denosumab

     Phase 2 · active · small_molecule

     Lung Cancer

     CT.gov ↗
417. NCT06755684

     Befotertinib combined Bevacizumab

     Phase 2 · active · small_molecule

     EGFR

     CT.gov ↗
418. NCT06772610

     Ensartinib group

     Phase 2 · active · small_molecule

     NSCLC

     CT.gov ↗
419. NCT06783790

     IIT2024097

     Phase 2 · active · small_molecule

     AML (Acute Myelogenous Leukemia)

     CT.gov ↗
420. NCT06831175

     Camrelizumab

     Phase 2 · active · small_molecule

     Adrenal Cortical Carcinoma

     CT.gov ↗
421. NCT06837948

     PM8002

     Phase 2 · active · small_molecule

     Locally Advanced Non-Small Cell Lung Cancer

     CT.gov ↗
422. NCT06855810

     Venetoclax

     Phase 3 · active · small_molecule

     Acute Lymphoblastic Leukemia

     CT.gov ↗
423. NCT06890143

     DAPA-PedHKD

     Phase 3 · active · small_molecule

     Pediatric Hereditary Kidney Diseases

     CT.gov ↗
424. NCT06901817

     Intraventricular Pemetrexed

     Phase 2 · active · small_molecule

     Leptomeningeal Metastasis

     CT.gov ↗
425. NCT06904183

     LEN+SIN+DEB-TACE+HAIC

     Phase 2 · active · other

     Hepatocellular Carcinoma Non-resectable

     CT.gov ↗
426. NCT06922240

     Riociguat

     Phase 3 · active · small_molecule

     Chronic Thromboembolic Pulmonary Hypertension

     CT.gov ↗
427. NCT06924762

     Placebo intramuscular injection

     Phase 3 · active · small_molecule

     Chronic Spontaneous Uriticaria

     CT.gov ↗
428. NCT06925048

     PD-1 inhbitor+SHR0302

     Phase 2 · active · small_molecule

     Non-Small Cell Lung Cancer

     CT.gov ↗
429. NCT06946836

     AK104

     Phase 2 · active · small_molecule

     Resectable Non-small Cell Lung Cancer

     CT.gov ↗
430. NCT06948981

     GT719 Injection

     Phase 2 · active · mab

     Hematological Malignancy (Leukemia- Lymphoma)

     CT.gov ↗
431. NCT06961201

     Nano-crystalline Megestrol Acetate Oral Suspension

     Phase 3 · active · small_molecule

     Extensive-stage Small Cell Lung Cancer (ES-SCLC)

     CT.gov ↗
432. NCT06971211

     FirstHCMU-JBi-PARTOM

     Phase 2 · active · small_molecule

     Metastatic Castration-resistant Prostate Cancer

     CT.gov ↗
433. NCT06987305

     Intravenous rhTNK-tPA

     Phase 3 · active · small_molecule

     Stroke, Acute Ischemic

     CT.gov ↗
434. NCT06987734

     Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab

     Phase 2 · active · small_molecule

     Lung Cancer (NSCLC)

     CT.gov ↗
435. NCT06991491

     GnP in combination with Ivonescimab and SBRT

     Phase 2 · active · other

     Pancreatic Cancer

     CT.gov ↗
436. NCT06996132

     Glofitamab

     Phase 2 · active · small_molecule

     Relapsed or Refractory Aggressive B-cell Lymphoma

     CT.gov ↗
437. NCT07010237

     Dose-attenuated IST and Hetrombopag

     Phase 2 · active · small_molecule

     Sever Aplastic Anaemia

     CT.gov ↗
438. NCT07020247

     Anti-PD-1 antibody drug named Serplulimab

     Phase 3 · active · small_molecule

     Locally Advanced Rectal Cancer (LARC)

     CT.gov ↗
439. NCT07024537

     FOLFOXIRI-based HAIC+Fuquinitinib

     Phase 2 · completed · small_molecule

     Colorectal Neoplasms

     CT.gov ↗
440. NCT07026994

     Colchicine 0.5mg

     Phase 2 · active · small_molecule

     Cerebral Amyloid Angiopathy

     CT.gov ↗
441. NCT07059832

     68Ga-NODAGA-SNA006

     Phase 2 · active · small_molecule

     Cancer

     CT.gov ↗
442. NCT07063199

     Daratumumab Injection

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
443. NCT07070622

     patients were assigned to receive TNT or iTNT management

     Phase 3 · active · small_molecule

     Rectal Cancer

     CT.gov ↗
444. NCT07072351

     SOX Chemotherapy

     Phase 2 · active · small_molecule

     Gastroesophageal Junction Adenocarcinoma

     CT.gov ↗
445. NCT07076095

     IBB0979

     Phase 2 · active · small_molecule

     Small Cell Lung Cancer

     CT.gov ↗
446. NCT07078721

     Fludarabine (FLU)

     Phase 2 · active · small_molecule

     Aplastic Anemia Idiopathic

     CT.gov ↗
447. NCT07101679

     LICSBR

     Phase 2 · active · small_molecule

     Locally Advanced Pancreatic Ductal Adenocarcinoma

     CT.gov ↗
448. NCT07106684

     BCMA CAR-T

     Phase 2 · active · mab

     Multiple Myeloma, Plasma Cell Leukemia

     CT.gov ↗
449. NCT07106723

     ASCT+CD7-CART

     Phase 2 · active · small_molecule

     CD7 Positive

     CT.gov ↗
450. NCT07109323

     BCMA CART

     Phase 2 · active · small_molecule

     Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm Definitions

     CT.gov ↗
451. NCT07115667

     BCMA/CD3 bispecific antibody (CM336)

     Phase 2 · active · small_molecule

     Solitary Bone Plasmacytoma

     CT.gov ↗
452. NCT07122895

     NMDAE

     Phase 2 · active · small_molecule

     Schizophrenia

     CT.gov ↗
453. NCT07127289

     Autologous hematopoietic stem cell infusion

     Phase 2 · active · mab

     Prolonged Cytopenia Following CAR-T Therapy

     CT.gov ↗
454. NCT07129629

     Bedaquiline (B)

     Phase 2 · active · small_molecule

     Tuberculosis, Pulmonary

     CT.gov ↗
455. NCT07132008

     Tislelizumab

     Phase 3 · active · small_molecule

     Colonic Neoplasms

     CT.gov ↗
456. NCT07132684

     Daunorubicin/Idarubicin

     Phase 3 · active · small_molecule

     AML, Adult

     CT.gov ↗
457. NCT07151326

     Cabozantinib

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
458. NCT07152613

     2025-I2M-C&T-B-090B

     Phase 3 · active · small_molecule

     Pneumocystis Jiroveci Pneumonia

     CT.gov ↗
459. NCT07153770

     Bozitinib

     Phase 2 · active · small_molecule

     NSCLC

     CT.gov ↗
460. NCT07165769

     Induction Therapy

     Phase 2 · active · small_molecule

     Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN

     CT.gov ↗
461. NCT07175480

     Intermittent PD-1/PD-L1 ICI + VEGFR-TKI

     Phase 2 · active · small_molecule

     Renal Cell Carcinoma (RCC)

     CT.gov ↗
462. NCT07177794

     toripalimab

     Phase 3 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
463. NCT07187908

     Efbemalenograstim alfa Injection

     Phase 2 · active · small_molecule

     Primary/Secondary Prevention

     CT.gov ↗
464. NCT07214142

     PD-1

     Phase 2 · active · small_molecule

     Rectal Cancer Patients

     CT.gov ↗
465. NCT07230301

     Adebrelimab (PD-L1 inhibitor)

     Phase 2 · active · small_molecule

     Pancreatic Cancer Metastatic

     CT.gov ↗
466. NCT07230574

     NK cell perfusion group

     Phase 2 · active · mab

     Abortion, Missed

     CT.gov ↗
467. NCT07239674

     desiccated thyroid extract (DTE)+levothyroxine (L-T4)

     Phase 3 · active · small_molecule

     Intermediate-to-High Risk Differentiated Thyroid Cancer

     CT.gov ↗
468. NCT07244874

     Sacituzumab tirumotecan

     Phase 2 · active · small_molecule

     TNBC - Triple-Negative Breast Cancer

     CT.gov ↗
469. NCT07253181

     [2025]372-001

     Phase 3 · active · small_molecule

     Acute Ischemic Stroke

     CT.gov ↗
470. NCT07259122

     IIT2025111

     Phase 2 · active · small_molecule

     Waldenström Macroglobulinemia (WM)

     CT.gov ↗
471. NCT07259161

     IIT2025094

     Phase 2 · active · small_molecule

     CML,Blast Phase

     CT.gov ↗
472. NCT07271992

     SG+I

     Phase 2 · active · small_molecule

     TNBC, Triple Negative Breast Cancer

     CT.gov ↗
473. NCT07272434

     Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)

     Phase 3 · active · mab

     Respiratory Syncytial Virus (RSV)

     CT.gov ↗
474. NCT07282483

     Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash

     Phase 2 · active · small_molecule

     Radiation-induced Oral Mucositis

     CT.gov ↗
475. NCT07291947

     Iparomlimab and Tuvonralimab Injection (QL1706)

     Phase 2 · active · small_molecule

     Cholangiocarcinoma

     CT.gov ↗
476. NCT07295938

     Chinese herbs-I

     Phase 2 · active · small_molecule

     Mycobacterium Abscessus Pulmonary Disease

     CT.gov ↗
477. NCT07297563

     Rituximab

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
478. NCT07311772

     Houyanqing Oral Liquid

     Phase 3 · active · small_molecule

     Nasopharyngeal Cancinoma (NPC)

     CT.gov ↗
479. NCT07321678

     ASC30 tablets

     Phase 2 · active · small_molecule

     T2DM (Type 2 Diabetes Mellitus)

     CT.gov ↗
480. NCT07323056

     Sacituzumab Tirumotecan and Limertinib

     Phase 2 · active · small_molecule

     EGFR-mutant Non-small Cell Lung Cancer

     CT.gov ↗
481. NCT07324018

     Hydrogel of spirulina-derived exosomes.

     Phase 2 · active · small_molecule

     Radiation-induced Esophagitis

     CT.gov ↗
482. NCT07353671

     Topical application of Periplaneta americana-derived Meilian Fuxin Solution

     Phase 3 · active · small_molecule

     Radiation-induced Dermatitis

     CT.gov ↗
483. NCT07362199

     Rituximab combined with Daratumumab（Anti-CD38 Monoclonal Antibody）

     Phase 2 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
484. NCT07367724

     Ademetionine 1,4-Butanedisulfonate

     Phase 2 · active · small_molecule

     Obstructive Hypertrophic Cardiomyopathy (oHCM)

     CT.gov ↗
485. NCT07369791

     Nivolumab

     Phase 2 · active · small_molecule

     Advanced Biliary Tract Cancer(BTC)

     CT.gov ↗
486. NCT07373964

     CSIIT-Q115

     Phase 2 · active · small_molecule

     Small Cell Lung Cancer

     CT.gov ↗
487. NCT07381075

     Becotatug Vedotin

     Phase 2 · active · small_molecule

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
488. NCT07388875

     Sacituzumab Tirumotecan

     Phase 2 · active · small_molecule

     Extensive-Stage Small Cell Lung Cancer

     CT.gov ↗
489. NCT07393438

     Acetohydroxamic Acid

     Phase 2 · active · small_molecule

     Multidrug-Resistant Tuberculosis

     CT.gov ↗
490. NCT07414758

     golidocitinib

     Phase 3 · active · small_molecule

     Peripheral T Cell Lymphoma

     CT.gov ↗
491. NCT07421856

     Autologous BCMA-targeting CAR T cells

     Phase 2 · active · mab

     Multiple Myeloma in Relapse

     CT.gov ↗
492. NCT07433387

     LP-98 20 mg

     Phase 2 · active · small_molecule

     HIV

     CT.gov ↗
493. NCT07441369

     Abemaciclib

     Phase 2 · active · small_molecule

     Liver Metastases From Colorectal Cancer (mCRC)

     CT.gov ↗
494. NCT07441954

     Induction therapy of GP(Pomalidomide+Obinutuzumab）

     Phase 2 · active · small_molecule

     Indolent Lymphoma

     CT.gov ↗
495. NCT07443488

     Olverembatinib+INO

     Phase 2 · active · small_molecule

     HSCT

     CT.gov ↗
496. NCT07447726

     CD19X CAR-T

     Phase 2 · active · small_molecule

     Large B-Cell Lymphoma (LBCL)

     CT.gov ↗
497. NCT07449910

     2mg Baricitinib

     Phase 3 · active · small_molecule

     Acute Ichemic Stroke

     CT.gov ↗
498. NCT07450313

     Luspatercept

     Phase 2 · active · small_molecule

     HSCT

     CT.gov ↗
499. NCT07469293

     Intra-arterial thrombolysis

     Phase 3 · active · other

     Acute Ischemic Stroke

     CT.gov ↗
500. NCT07471282

     Tenecteplase (0.0938mg/kg)

     Phase 3 · active · small_molecule

     Stroke

     CT.gov ↗
501. NCT07472933

     2026（225）

     Phase 2 · active · small_molecule

     Cancer of Biliary Duct

     CT.gov ↗
502. NCT07476872

     Gecacitinib

     Phase 2 · active · small_molecule

     cGVHD

     CT.gov ↗
503. NCT07483359

     HAIC + Tislelizumab +lenvatinib

     Phase 2 · active · other

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
504. NCT07490288

     Venetoclax

     Phase 3 · active · small_molecule

     AML

     CT.gov ↗
505. NCT07491783

     Carbon Nanoparticle Iron Suspension for Injection

     Phase 2 · active · small_molecule

     HNSCC

     CT.gov ↗
506. NCT07509398

     Standard First-Line Therapy

     Phase 3 · active · small_molecule

     Unresectable Colorectal Cancer

     CT.gov ↗
507. NCT07518979

     Becotatug Vedotin

     Phase 2 · active · small_molecule

     Penile Cancer

     CT.gov ↗
508. NCT07534644

     HS_SW01 cells injection

     Phase 2 · active · small_molecule

     Ankylosing Spondylitis

     CT.gov ↗
509. NCT07537257

     Ventoclax

     Phase 3 · active · small_molecule

     AML (Acute Myelogenous Leukemia)

     CT.gov ↗
510. NCT07539818

     Venetoclax

     Phase 3 · active · small_molecule

     AML

     CT.gov ↗
511. NCT07551895

     HS_SW01 cells injection

     Phase 2 · active · small_molecule

     Primary Ovarian Insufficiency (Poi)

     CT.gov ↗
512. NCT07555470

     Mosunetuzumab

     Phase 2 · active · small_molecule

     Follicular Lymphoma

     CT.gov ↗
513. NCT07560410

     Alectinib

     Phase 2 · active · small_molecule

     Bone Cancer

     CT.gov ↗
514. NCT07569679

     Gemcitabine plus Cisplatin

     Phase 2 · active · small_molecule

     Biliary Tract Cancer

     CT.gov ↗
515. NCT07572864

     Engineered Mitochondrial Vaccine (IMP3-Mito)

     Phase 2 · active · mab

     Head and Neck Squamous Cell Carcinoma

     CT.gov ↗
516. NCT07576660

     Dexamethasone

     Phase 3 · active · small_molecule

     Acute Respiratory Distress Syndrome (ARDS)

     CT.gov ↗
517. NCT07585747

     Orelabrutinib

     Phase 2 · active · small_molecule

     Follicular Lymphoma

     CT.gov ↗
518. NCT07585760

     CM336 Plus Isatuximab

     Phase 2 · active · small_molecule

     Multiple Myeloma (MM)

     CT.gov ↗
519. NCT07595172

     NALIRIFOX+Adebrelimab

     Phase 2 · active · small_molecule

     Pancreatic Ductal Adenocarcinoma (PDAC)

     CT.gov ↗